Lactobacillus johnsonii n6.2 modulates the host immune responses: a double-blind, randomized trial in healthy adults

HIGHLIGHTS

• who: Wendy J. Dahl and Graciela L. Lorca from the Utrecht University, Biomodels LLC, United States have published the research work: Lactobacillus johnsonii N6.2 Modulates the Host Immune Responses: A Double-Blind, Randomized Trial in Healthy Adults, in the Journal: (JOURNAL)
• what: The aim of this study was to assess the safety and tolerability of L johnsonii N6.2. This study provides supporting data that the tool is sufficiently sensitive to detect differences in healthy individuals. The authors determined the concentrations of several intermediates in the tryptophan degradation pathway. The decrease in CD8+ Tn . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.